Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
As of April 2025 Biogen has a market cap of โน1.491 Trillion. This makes Biogen the world's 1073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โน1.491 T | -21.15% |
2024 | โน1.891 T | -39.4% |
2023 | โน3.121 T | -5.41% |
2022 | โน3.299 T | 25.8% |
2021 | โน2.623 T | -4.81% |
2020 | โน2.755 T | -25.24% |
2019 | โน3.686 T | -11.16% |
2018 | โน4.149 T | -3.54% |
2017 | โน4.301 T | 2.6% |
2016 | โน4.192 T | -5.79% |
2015 | โน4.450 T | -11.81% |
2014 | โน5.046 T | 23.63% |
2013 | โน4.081 T | 115.29% |
2012 | โน1.896 T | 34.07% |
2011 | โน1.414 T | 95.68% |
2010 | โน722.69 B | 5.92% |
2009 | โน682.30 B | 3.47% |
2008 | โน659.43 B | -0.17% |
2007 | โน660.53 B | -10.07% |
2006 | โน734.47 B | 6.2% |
2005 | โน691.58 B | -29.44% |
2004 | โน980.11 B |
On Apr 24th, 2025 the market cap of Biogen was reported to be: